Status:
COMPLETED
N-Acetylcysteine in Severe Acute Alcoholic Hepatitis
Lead Sponsor:
Erasme University Hospital
Conditions:
Alcoholic Hepatitis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Acute alcoholic hepatitis (AAH) is the most severe form of alcoholic liver disease (ALD) and is associated with a high risk of dying in the short term. Corticosteroids are generally recommended in pat...
Eligibility Criteria
Inclusion
- Biopsy proven alcoholic hepatitis
- Severe disease defined by a Maddrey score superior to 32
Exclusion
- Neoplastic disease compromising 6 months survival
- HIV patients
- Hepatorenal syndrome
Key Trial Info
Start Date :
September 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00962442
Start Date
September 1 2000
Last Update
August 20 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasme University Hospital
Brussels, Belgium, 1070